At 7.3% CAGR, the Asia Pacific Endoscopy Procedures Market is Projected to be Worth US$  14,103.00 million by 2030, Says Business Market Insights

According to Business Market Insights research, the Asia Pacific endoscopy procedures market was valued at US$ 8,044.94 million in 2022 and is expected to reach US$ 14,103.00 million by 2030, registering a CAGR of 7.3% from 2022 to 2030. Technological advancements leading to enhanced applications and increasing prevalence of cancer attributed to the Asia Pacific endoscopy procedures market expansion.        

On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA approval of the GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer. On December 2019, Boston Scientific Corporation launched “EXALT Model D” a Single-Use Duodenoscope for endoscopic retrograde cholangiopancreatography procedures. This is the world’s first single use duodenoscope. The third generation EXALT Model D Single-Use Duodenoscope has incorporated several design updates based on physician feedback that are intended to improve the overall user experience. Thus, all these recent developments are expected to provide growth opportunities for the market over the forecast period.

On the contrary, risks of infections associated with endoscopic procedures hampers the Asia Pacific endoscopy procedures market.  

Based on procedure, the Asia Pacific endoscopy procedures market is segmented into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. The arthroscopy and bronchoscopy segment held 24.2% share of Asia Pacific endoscopy procedures market in 2022, amassing US$ 1,943.51 million. It is projected to garner US$ 3,633.72 million by 2030 to expand at 8.1% CAGR during 2022–2030. 

Based on offering, the Asia Pacific endoscopy procedures market is segmented into endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps’ traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights etc.). The endoscopes segment held 32.8% share of Asia Pacific endoscopy procedures market in 2022, amassing US$ 2,641.70 million. It is projected to garner US$ 4,696.36 million by 2030 to expand at 7.5% CAGR during 2022–2030.

Based on product type, the Asia Pacific endoscopy procedures market is bifurcated into disposable and reusable. The reusable segment held 78.1% share of Asia Pacific endoscopy procedures market in 2022, amassing US$ 6,284.99 million. It is projected to garner US$ 10,337.73 million by 2030 to expand at 6.4% CAGR during 2022–2030.

Based on end user, the Asia Pacific endoscopy procedures market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. The hospitals and clinics segment held 58.5% share of Asia Pacific endoscopy procedures market in 2022, amassing US$ 4,705.79 million. It is projected to garner US$ 8,146.63 million by 2030 to expand at 7.1% CAGR during 2022–2030.

Based on country, the Asia Pacific endoscopy procedures market has been categorized into the India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 37.1% share of Asia Pacific endoscopy procedures market in 2022. It was assessed at US$ 2,988.57 million in 2022 and is likely to hit US$ 5,272.85 million by 2030, exhibiting a CAGR of 7.4% during 2022–2030.      

Key players operating in the Asia Pacific endoscopy procedures market are Stryker Corp, FUJIFILM Holdings Corp, Merit Medical Systems Inc, Smith & Nephew Plc, Arthrex Inc, Steris Plc, Conmed Corp, Olympus Corp, Boston Scientific Corp, and Cook Medical LLC, among others.

• In May-2023, Stryker had completed the acquisition of Cerus Endovascular Ltd. The acquisition of Cerus Endovascular is highly complementary to Stryker’s Neurovascular business and strengthens the hemorrhagic portfolio globally.
• In Jun-2022, Stryker had opened its new research and development facility, Stryker’s Global Technology Centre, at the International Tech Park, Gurgaon. The 150,000-square-foot facility further supported the company’s mission to make healthcare better.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com